Search This Blog

Tuesday, May 31, 2022

EW Healthcare Partners to acquire TherapeuticsMD

 TherapeuticsMD, Inc. (NASDAQ: TXMD) ("TherapeuticsMD," "TXMD" or the "Company"), an innovative, leading women’s healthcare company, today announced that it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners, a private equity firm dedicated to making investments in rapidly growing healthcare companies.

Under the terms of the transaction, which has been unanimously approved by TXMD’s board of directors, EW Healthcare Partners will commence a tender offer to acquire all outstanding shares of TXMD common stock for $10.00 per share in an all-cash transaction, followed immediately by a merger. The purchase price represents a premium of 367.3% over TherapeuticsMD’s closing share price on May 27, 2022.

https://finance.yahoo.com/news/therapeuticsmd-ew-healthcare-partners-announce-100000094.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.